Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria
1 other identifier
interventional
98
1 country
1
Brief Summary
Placenta previa cases are one of the difficult groups of patients to manage in modern obstetrics. When the literature is evaluated extensively, no clear information can be seen especially in terms of hospitalization time. Inpatient follow-up of this patients has negative effects like hospital infections in terms of the patient, workload in terms of health personnel and financial losses in terms of the country's economy. Placenta previa cases are complicated patients in which generalizations cannot be easily performed and they should be monitored at third level hospitals. In addition, care should be personalized considering the many reasons. In this study, placenta previa cases will be followed up at 28th gestational week and evaluated at 32nd week by vaginal ultrasonography and MRI and this follow-up will continue until delivery. Thus, in this study, it was aimed to determine the parameters that would allow systematic personalization of health service in this particular patient group by making risk assessment of placenta previa cases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 3, 2018
CompletedStudy Start
First participant enrolled
November 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2020
CompletedFirst Posted
Study publicly available on registry
February 11, 2020
CompletedMarch 23, 2022
March 1, 2022
1.2 years
November 3, 2018
March 21, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The number of placental invasion pathologies
Placental invasion pathologies detected during delivery will be evaluated.
1 day
The number of preterm birth
The relation between preterm birth and placental invasion pathologies will be assessed.
1 day
Study Arms (1)
Placenta Previa
EXPERIMENTALPlacenta previa cases will be evaluated at 32nd week by vaginal ultrasonography and MRI.
Interventions
Placenta previa cases will be evaluated at 32nd week by vaginal ultrasonography for invasion anomaly and preterm birth.
Placenta previa cases will be evaluated at 32nd week by MRI for invasion anomaly and preterm birth.
Eligibility Criteria
You may qualify if:
- Monitoring of placenta previa
- To apply before the 28th week
- To have a low-risk second trimester screening test
- No malformation detected in the anomaly screening
You may not qualify if:
- Multiple pregnancies
- Pregnancy complicated with preeclampsia
- Pregnancy complicated by gestational hypertension
- Pregnancy complicated by gestational diabetes mellitus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ege Universitylead
Study Sites (1)
Ege University Hospital
Izmir, 35100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sabahattin a Arı, MD
Ege University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 3, 2018
First Posted
February 11, 2020
Study Start
November 13, 2018
Primary Completion
February 1, 2020
Study Completion
February 1, 2020
Last Updated
March 23, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share